Showing 2941-2960 of 7110 for: Cochrane Systematic Reviews Back
- Inhaled cromones for prolonged non-specific cough in children
Cochrane Systematic Reviews, 20-Jul-2010
Non-specific cough is defined as non-productive cough in the absence of identifiable respiratory disease or known aetiology. It is commonly seen in paediatric practice. These children are treated with a variety of therapies including inhaled cromones.
- Inhaled hyperosmolar agents for bronchiectasis
Cochrane Systematic Reviews, 9-May-2014
Mucus retention in the lungs is a prominent feature of bronchiectasis. The stagnant mucus becomes chronically colonised with bacteria, which elicit a host neutrophilic response. This fails to eliminate the bacteria, and the large concentration of host-der
- Inhaled insulin in diabetes mellitus
Cochrane Systematic Reviews, 8-Oct-2008
Insulin therapy often relies on multiple daily injections of insulin. However this is a considerable burden to many people with diabetes and adherence to such an insulin regimen can be difficult to maintain, hence compromising optimal glycaemic control. A
- Inhaled magnesium sulfate in the treatment of acute asthma
Cochrane Systematic Reviews, 28-Nov-2017
Asthma exacerbations can be frequent and range in severity from mild to life-threatening. The use of magnesium sulfate (MgSO4) is one of numerous treatment options available during acute exacerbations. While the efficacy of intravenous MgSO4 has been demo
- Inhaled mannitol for cystic fibrosis
Cochrane Systematic Reviews, 7-Oct-2015
Several agents are used to clear secretions from the airways of people with cystic fibrosis. Inhaled dry powder mannitol is now available in Australia and some countries in Europe. The exact mechanism of action of mannitol is unknown, but it increases muc
- Inhaled nitric oxide for acute chest syndrome in people with sickle cell disease
Cochrane Systematic Reviews, 24-Jan-2013
Acute chest syndrome has been defined as a new infiltrate visible on chest radiograph associated with one or more symptoms, such as fever, cough, sputum production, tachypnoea, dyspnoea, or new-onset hypoxia. Symptoms and complications of this syndrome, w
- Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) and acute lung injury in children and adults
Cochrane Systematic Reviews, 11-Feb-2013
Acute hypoxaemic respiratory failure (AHRF), defined as acute lung injury (ALI) and acute respiratory distress syndrome (ARDS), are critical conditions. AHRF results from a number of systemic conditions and is associated with high mortality and morbidity
- Inhaled nitric oxide for respiratory failure in preterm infants
Cochrane Systematic Reviews, 9-Nov-2010
Inhaled nitric oxide (iNO) is effective in term infants with hypoxic respiratory failure. The pathophysiology of respiratory failure and the potential risks of iNO differ substantially in preterm infants, necessitating study in this population.
- Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease
Cochrane Systematic Reviews, 3-Jul-2014
Nitric oxide (NO) is a prevalent molecule in humans that is responsible for many physiologic activities including pulmonary vasodilation. An exogenous, inhaled form (iNO) exists that mimics this action without affecting systemic blood pressure. This thera
- Inhaled non‐steroid anti‐inflammatories for children and adults with bronchiectasis
Cochrane Systematic Reviews, 27-Jan-2016
Chronic neutrophilic inflammation, in both the presence and absence of infection, is a feature of bronchiectasis in adults and children. The anti-inflammatory properties of non-steroid anti-inflammatory drugs (NSAIDs) may be beneficial in reducing airway
- Inhaled short acting beta2-agonist use in chronic asthma: regular versus as needed treatment
Cochrane Systematic Reviews, 29-Mar-2009
Inhaled short-acting beta-2 agonists are the major class of bronchodilators used for relief of symptoms in asthma. There has been concern that excessive uncontrolled use of beta-2 agonists might have contributed to rises in asthma mortality seen in some c
- Inhaled short-acting beta2-agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 29-Jul-2008
Inhaled short acting beta2 adrenergic agonists and ipratropium bromide are both used in the treatment of acute exacerbations of chronic obstructive pulmonary disease.
- Inhaled sodium cromoglycate for asthma in children
Cochrane Systematic Reviews, 6-Dec-2010
Sodium cromoglycate has been recommended as maintenance treatment for childhood asthma for many years. Its use has decreased since 1990, when inhaled corticosteroids became popular, but it is still used in many countries.
- Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 4-Dec-2014
Inhaled corticosteroids (ICS) are anti-inflammatory drugs that have proven benefits for people with worsening symptoms of chronic obstructive pulmonary disease (COPD) and repeated exacerbations. They are commonly used as combination inhalers with long-act
- Inhaled steroids for acute asthma following emergency department discharge
Cochrane Systematic Reviews, 13-Nov-2012
Patients with acute asthma treated in the emergency department (ED) are frequently treated with inhaled beta2-agonists and systemic corticosteroids after discharge. The use of inhaled corticosteroids (ICS) following discharge may also be beneficial in imp
- Inhaled steroids for bronchiectasis
Cochrane Systematic Reviews, 10-Mar-2011
Bronchiectasis is increasingly recognized as a major cause of respiratory morbidity especially in developing countries and in some ethnic populations of affluent countries. It is characterized by irreversible dilatation of airways, generally associated wi
- Inhaled steroids for episodic viral wheeze of childhood
Cochrane Systematic Reviews, 29-Sep-2008
Recurrent episodic wheeze in association with viral upper respiratory tract infection (URTI) is a specific clinical illness distinct from persistent atopic asthma.
- Inhaled versus oral steroids for adults with chronic asthma
Cochrane Systematic Reviews, 21-Aug-2008
Steroids are a common treatment of chronic asthma as a maintenance therapy in both developed and developing countries across the world. The cost of inhaled steroids means that in developing countries their availability is limited, leading to poorly contro
- Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates
Cochrane Systematic Reviews, 4-Apr-2012
Chronic lung disease (CLD) remains an important cause of mortality and morbidity in preterm infants and inflammation plays an important role in its pathogenesis. The use of inhaled corticosteroids may modulate the inflammatory process without concomitant
- Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants
Cochrane Systematic Reviews, 4-Apr-2012
Chronic lung disease (CLD) remains a serious and common problem among very low birth weight (VLBW) infants despite the use of antenatal steroids and postnatal surfactant therapy to decrease the incidence and severity of respiratory distress syndrome. Due
